We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+20.42%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$12.8M
(+15%)
Cap. Flow
+$4.19M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
128
New
12
Increased
26
Reduced
31
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tactile Systems Technology
TCMD
|
+$1.49M |
| 2 |
SRDX
Surmodics
SRDX
|
+$1.2M |
| 3 |
AVP
Avon Products, Inc.
AVP
|
+$1.12M |
| 4 |
ASRT
Assertio
ASRT
|
+$964K |
| 5 |
Apyx Medical
APYX
|
+$945K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$1.98M |
| 2 |
ePlus
PLUS
|
+$1.49M |
| 3 |
Boston Scientific
BSX
|
+$1.18M |
| 4 |
OUTR
OUTERWALL INC
OUTR
|
+$853K |
| 5 |
LeMaitre Vascular
LMAT
|
+$480K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.72% |
| 2 | Technology | 12.42% |
| 3 | Industrials | 8.59% |
| 4 | Consumer Staples | 7.17% |
| 5 | Communication Services | 2.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$2.77B
| $5.61M | 5.61% |
620,908
-11,000
| -2% | -$89.4K |
|
2
NeoGenomics
NEO
$2.32B
| $5.39M | 5.39% |
655,800
-17,232
| -3% | -$145K |
|
|
STJ
3
DELISTED
St Jude Medical
STJ
| $5.32M | 5.32% |
66,673
| – | – |
|
|
4
Apyx Medical
APYX
$130M
| $3.37M | 3.37% |
647,035
+291,295
| +82% | +$945K |
|
5
Rockwell Medical
RMTI
$32.9M
| $2.97M | 2.97% |
4,030
-321
| -7% | -$260K |
|
|
CSII
6
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.65M | 2.65% |
111,600
| – | – |
|
7
Altimmune
ALT
$605M
| $2.38M | 2.38% |
2,733
-147
| -5% | -$115K |
|
|
8
LeMaitre Vascular
LMAT
$1.84B
| $2.2M | 2.2% |
110,883
-27,475
| -20% | -$480K |
|
9
AtriCure
ATRC
$2.47B
| $1.93M | 1.92% |
121,700
+36,600
| +43% | +$563K |
|
|
ASRT
10
DELISTED
Assertio
ASRT
| $1.9M | 1.9% |
1,268
+768
| +154% | +$964K |
|
|
SNAK
11
DELISTED
Inventure Foods, Inc.
SNAK
| $1.87M | 1.87% |
198,750
-1,000
| -0.5% | -$9.02K |
|
12
Pfizer
PFE
$159B
| $1.85M | 1.85% |
57,579
-1,054
| -2% | -$35.2K |
|
|
13
Tactile Systems Technology
TCMD
$525M
| $1.81M | 1.81% |
+96,961
| New | +$1.49M |
|
|
CGNT
14
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.78M | 1.78% |
979,610
-36,461
| -4% | -$47.2K |
|
15
Eli Lilly
LLY
$1.05T
| $1.58M | 1.58% |
19,700
| – | – |
|
16
Idexx Laboratories
IDXX
$43.7B
| $1.58M | 1.58% |
14,000
| – | – |
|
|
VYNT
17
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $1.51M | 1.51% |
5,764
+1,889
| +49% | +$579K |
|
|
CTLP
18
DELISTED
Cantaloupe
CTLP
| $1.35M | 1.35% |
240,400
+2,000
| +0.8% | +$9.86K |
|
|
SRDX
19
DELISTED
Surmodics
SRDX
| $1.32M | 1.32% |
+43,750
| New | +$1.2M |
|
20
Microsoft
MSFT
$3.81T
| $1.29M | 1.29% |
22,460
+3,725
| +20% | +$210K |
|
|
SVU
21
DELISTED
SUPERVALU Inc.
SVU
| $1.29M | 1.29% |
36,879
-285
| -0.8% | -$10.1K |
|
|
AVP
22
DELISTED
Avon Products, Inc.
AVP
| $1.27M | 1.27% |
+224,500
| New | +$1.12M |
|
|
ZIXI
23
DELISTED
Zix Corporation
ZIXI
| $1.24M | 1.24% |
301,549
-1,990
| -0.7% | -$7.86K |
|
|
TEAR
24
DELISTED
TearLab Corporation
TEAR
| $1.2M | 1.2% |
184,824
+9,300
| +5% | +$69.1K |
|
25
Abbott
ABT
$195B
| $1.19M | 1.19% |
28,175
+2,100
| +8% | +$90K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Perkins Capital Management held 128 positions worth $100M, up 15% from $87.2M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management deployed $4.19M of net new capital in Q3 2016, opening 12 new positions and adding to 26 existing holdings. Its largest new stake was Tactile Systems Technology: 96,961 shares worth $1.81M.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 60% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $1.98M trimmed.
- Perkins Capital Management's largest Q3 2016 buy was Tactile Systems Technology: 96,961 shares worth $1.81M.
- Perkins Capital Management added most to Assertio in Q3 2016, an estimated $964K increase.
- Perkins Capital Management's biggest Q3 2016 reduction was BioTelemetry, Inc., cutting an estimated $1.98M.
- Perkins Capital Management fully exited Boston Scientific in Q3 2016, selling an estimated $1.18M.
- Perkins Capital Management's ten largest holdings make up 34% of its $100M portfolio in Q3 2016.
- Perkins Capital Management opened 12 new positions and closed 16 in Q3 2016.
- Perkins Capital Management's portfolio value rose 15% quarter-over-quarter to $100M.
Based on Perkins Capital Management's 13F filing for Q3 2016, filed 4 Nov 2016.